PCM
CDMO
Portolan Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-455,038
| Closed | -$5.62M | – | 151 |
|
2024
Q4 | $5.62M | Sell |
455,038
-1,638,953
| -78% | -$20.2M | 0.38% | 82 |
|
2024
Q3 | $23.8M | Buy |
2,093,991
+273,212
| +15% | +$3.11M | 1.73% | 14 |
|
2024
Q2 | $13M | Buy |
1,820,779
+953,894
| +110% | +$6.81M | 1.07% | 27 |
|
2024
Q1 | $5.81M | Buy |
866,885
+428,283
| +98% | +$2.87M | 0.44% | 80 |
|
2023
Q4 | $2.85M | Buy |
+438,602
| New | +$2.85M | 0.25% | 96 |
|
2023
Q1 | – | Sell |
-35,108
| Closed | -$483K | – | 174 |
|
2022
Q4 | $483K | Sell |
35,108
-29,201
| -45% | -$402K | 0.05% | 128 |
|
2022
Q3 | $1.23M | Sell |
64,309
-127,862
| -67% | -$2.45M | 0.13% | 121 |
|
2022
Q2 | $2.93M | Sell |
192,171
-26,954
| -12% | -$411K | 0.3% | 101 |
|
2022
Q1 | $4.46M | Buy |
219,125
+3,110
| +1% | +$63.4K | 0.36% | 90 |
|
2021
Q4 | $6.3M | Buy |
216,015
+119,611
| +124% | +$3.49M | 0.42% | 77 |
|
2021
Q3 | $2.08M | Sell |
96,404
-221,149
| -70% | -$4.77M | 0.15% | 117 |
|
2021
Q2 | $8.15M | Sell |
317,553
-273,679
| -46% | -$7.02M | 0.59% | 67 |
|
2021
Q1 | $10.8M | Sell |
591,232
-527,390
| -47% | -$9.61M | 0.85% | 45 |
|
2020
Q4 | $12.9M | Buy |
1,118,622
+155,248
| +16% | +$1.79M | 1.17% | 23 |
|
2020
Q3 | $7.34M | Buy |
963,374
+528,662
| +122% | +$4.03M | 0.83% | 47 |
|
2020
Q2 | $2.85M | Buy |
+434,712
| New | +$2.85M | 0.33% | 97 |
|